- Advanced search
- Immuno Portal
- Malaria Portal
Compound class: Synthetic organic
Comment: This is the most potent antimalarial compound from a novel series of diaminopyridines claimed in Eisai's patent WO2021149692A1 .
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
1. Horii T, Suzuki S, Roupany AJA, Mui JJB, Lewis-Marshall JP, Devan FA, Cartwright MW. (2021)
Novel antimalarial agent containing heterocyclic compound.
Patent number: WO2021149692A1. Assignee: Eisai R&D Management Co., Ltd.. Priority date: 21/01/2020. Publication date: 29/07/2021.